Medical Imaging (6637) Fundamentals 2026 — P/E 9.3x, Revenue Analysis | SniperIQ
Medical Imaging (6637) is a TW-listed Healthcare company in Medical - Distribution with a market capitalization of NT
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Medical Imaging's market cap?
Medical Imaging (6637) has a market capitalization of approximately NT
What is Medical Imaging's P/E ratio?
Medical Imaging's trailing twelve-month P/E ratio is 9.3x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Medical Imaging?
Medical Imaging runs a net profit margin of 14.7%, a gross margin of 28.0%, and an operating margin of 18.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Medical Imaging generate?
Medical Imaging reported revenue of NT
Does Medical Imaging pay a dividend?
Medical Imaging offers a trailing dividend yield of about 5.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Medical Imaging financially healthy?
Medical Imaging carries a debt-to-equity ratio of 0.38x and a current ratio of 3.59x, with a market beta of 0.13. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Medical Imaging a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medical Imaging (6637) the key facts are: market cap NT
Track Medical Imaging's full fundamentals live
Get Medical Imaging's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.